Latest Articles
![Lamine Mbow, Global Head of Cancer Immunology and Immune Modulation, shares our approach to Immuno-oncology Lamine Mbow, Global Head of Cancer Immunology and Immune Modulation at Boehringer Ingelheim, shares our approach to Immuno-oncology](/sites/default/files/2023-05/Lamine_Mbow_Tcell_Engagers.jpg)
Science Stories
T-cell engagers: Reawakening T-cells to fight cancer
Lamine Mbow, our Global Head of Cancer Immunology and Immune Modulation, shares our approach to immuno-oncology, highlighting our T-cell engagers platform and how we are driving innovation to deliver meaningful advances to people with cancer.
Read more
![Biopharmaceuticals Biopharmaceuticals](/sites/default/files/2023-04/rollup_EN_biopharmaceuticals.png)
Science Stories
Biopharmaceuticals: Large molecules, enormous potential
Researching, developing and manufacturing biopharmaceuticals is a highly complex and lengthy process, but it has enormous potential.
Read more
![Digital twins are revolutionizing drug development Digital twins are revolutionizing drug development](/sites/default/files/2022-09/DT_Header_V01.png)
Science Stories
Revolutionizing drug development
Our scientists are leveraging the "digital twins"-technology to revolutionize biotherapeutic drug development.
Read more